K S Raevskii
Overview
Explore the profile of K S Raevskii including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
138
Citations
78
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Raevskii K, Narkevich V, Klodt P, Kudrin V
Eksp Klin Farmakol
. 2012 Mar;
74(12):3-7.
PMID: 22379873
Effects of separate and combined introduction of afobazole and SB-200646A (highly selective 5-HT2B/2C receptor antagonist) on the content of monoamines and their metabolites in brain structures of mice of C57/Bl/6...
2.
Khaindrava V, Kozina E, Kudrin V, Kucheryanu V, Klodt P, Narkevich V, et al.
Bull Exp Biol Med
. 2012 Jan;
150(5):566-9.
PMID: 22235385
Degeneration of dopaminergic (DAergic) neurons of the nigrostriatal system is the key stage in the pathogenesis of Parkinson's disease. The first symptoms of this disease are observed after degeneration of...
3.
Malikova L, Fedotova I, Surina N, Poletaeva I, Raevskii K
Eksp Klin Farmakol
. 2010 Sep;
73(7):2-5.
PMID: 20821971
The novel antiepileptic drug levetiracetam (keppra, 80 mg/kg, i.p.) produces a pronounced anticonvulsant effect on all parameters of the audiogenic locomotion response in Wistar rats, leading to the prevention of...
4.
Khaindrava V, Kozina E, Kucherianu V, KRYZHANOVSKII G, Kudrin V, Klodt P, et al.
Zh Nevrol Psikhiatr Im S S Korsakova
. 2010 Jul;
110(7):41-7.
PMID: 20639856
The first symptoms of Parkinson's disease manifest 20-30 years after the disease onset when the most dopaminergic neurons degenerated. Therefore, it is necessary to work out preclinical diagnostics and preventive...
5.
Kozina E, Khaindrava V, Kudrin V, Kucherianu V, Klodt P, Bocharov E, et al.
Ross Fiziol Zh Im I M Sechenova
. 2010 Jun;
96(3):270-82.
PMID: 20535997
The dopaminergic nigrostriatal system is a key component of regulation of the motor behaviour. Cell bodies of dopaminergic DA-ergic neurons are located in the compact zone of the substantia nigra,...
6.
Nasyrova D, Sapronova A, Balbashev A, Kudrin V, Klodt P, Raevskii K, et al.
Zh Evol Biokhim Fiziol
. 2009 Apr;
45(1):68-74.
PMID: 19370991
The work deals with study of development of central and peripheral serotonin-producing systems in rat ontogenesis before and after formation of the blood-brain barrier. By the method of highly efficient...
7.
Narkevich V, Kudrin V, Klodt P, Pokrovskii A, Kozlovskaia M, Maiskii A, et al.
Eksp Klin Farmakol
. 2008 Dec;
71(5):8-12.
PMID: 19093364
The effect of heptapeptide selank on the content of neurotransmitter monoamines and its metabolites in the brain structures of BALB/C and C57Bl/6 line mice under conditions of the open-field test...
8.
Fedotova I, Surina N, Malikova L, Raevskii K, Poletaeva I
Zh Vyssh Nerv Deiat Im I P Pavlova
. 2008 Nov;
58(5):620-7.
PMID: 19004322
The duration and severity of cataleptic freezing after audiogenic seizures were investigated in rats of several genotypes with different predisposition to audiogenic epilepsy. These genotypes were the Krushinsky-Molodkina strain (KM--the...
9.
Malikova L, Fedotova I, Poletaeva I, Raevskii K
Eksp Klin Farmakol
. 2008 Mar;
70(6):3-5.
PMID: 18318185
The new antiepileptic drug levetiracetam (LVT) at doses of 40 and 80 mg/kg exhibits a pronounced anticonvulsant effect, influencing all the parameters of audiogenic epileptiform seizures (AES) in Krushinsky-Molodkina (KM)...
10.
Raevskii K, Malikova L, Kalinin V
Eksp Klin Farmakol
. 2007 May;
70(2):70-4.
PMID: 17523458
Published data on the mechanisms involved in the action of levetiracetam (LVT, 2S-(oxo-1-pyrrolidinyl)butanoic acid amide), a widely used agent for the adjunctive therapy of partial epilepsy of different genesis, have...